| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-11-02 | 2009-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 4,762 | No Change | 0 | 0 % | $249,672 | $267,863 | $18,191 | 7.28 % | $0 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2009-07-31 | 2009-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 4,762 | Sold Some | -322 | -6.33 % | $296,720 | $267,863 | $-28,858 | -9.72 % | $1,951 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2009-04-24 | 2009-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 5,084 | Added More | 212 | 4.35 % | $253,336 | $285,975 | $32,639 | 12.88 % | $1,361 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2009-01-28 | 2008-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 4,872 | Sold Some | -200 | -3.94 % | $266,742 | $274,050 | $7,308 | 2.73 % | $-300 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2008-11-04 | 2008-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 5,072 | Sold Some | -537 | -9.57 % | $307,211 | $285,300 | $-21,911 | -7.13 % | $2,320 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2008-08-22 | 2008-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 5,609 | Sold Some | -513 | -8.37 % | $359,032 | $315,506 | $-43,526 | -12.12 % | $3,981 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2008-04-30 | 2008-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 6,122 | Sold Some | -1,025 | -14.34 % | $256,328 | $344,363 | $88,034 | 34.34 % | $-14,740 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2008-02-12 | 2007-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 7,147 | Sold Some | -5,178 | -42.01 % | $332,621 | $402,019 | $69,397 | 20.86 % | $-50,278 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2007-10-31 | 2007-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 12,325 | Sold Some | -24,843 | -66.83 % | $716,206 | $693,281 | $-22,925 | -3.20 % | $46,208 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2007-08-09 | 2007-06-30 | 13F-HR/A | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 37,168 | Sold Some | -4,145 | -10.03 % | $1,895,196 | $2,090,700 | $195,504 | 10.31 % | $-21,803 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2007-07-20 | 2007-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 41,313 | Added More | 2,440 | 6.27 % | $2,320,964 | $2,323,856 | $2,892 | 0.12 % | $171 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2007-01-31 | 2006-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 38,873 | Added More | 511 | 1.33 % | $2,735,493 | $2,186,606 | $-548,887 | -20.06 % | $-7,215 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2006-10-30 | 2006-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 38,362 | Sold Some | -3,990 | -9.42 % | $2,934,693 | $2,157,863 | $-776,831 | -26.47 % | $80,798 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2006-07-31 | 2006-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 42,352 | Sold Some | -700 | -1.62 % | $2,952,358 | $2,382,300 | $-570,058 | -19.30 % | $9,422 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2006-05-04 | 2006-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 43,052 | Added More | 1,070 | 2.54 % | $2,882,331 | $2,421,675 | $-460,656 | -15.98 % | $-11,449 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2006-02-06 | 2005-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 41,982 | Added More | 3,010 | 7.72 % | $3,085,677 | $2,361,488 | $-724,190 | -23.46 % | $-51,923 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2005-10-18 | 2005-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 38,972 | Added More | 1,394 | 3.70 % | $2,956,806 | $2,192,175 | $-764,631 | -25.86 % | $-27,350 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2005-07-25 | 2005-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 37,578 | Added More | 6,350 | 20.33 % | $3,046,448 | $2,113,763 | $-932,686 | -30.61 % | $-157,607 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2005-05-24 | 2005-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 31,228 | Added More | 5,405 | 20.93 % | $1,952,687 | $1,756,575 | $-196,112 | -10.04 % | $-33,943 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2005-04-05 | 2004-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 25,823 | Added More | 13,392 | 107.73 % | $1,494,119 | $1,452,544 | $-41,575 | -2.78 % | $-21,561 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2005-04-05 | 2004-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 12,431 | Sold Some | -1,060 | -7.85 % | $719,258 | $699,244 | $-20,014 | -2.78 % | $1,707 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2004-07-30 | 2004-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 13,491 | Added More | 80 | 0.59 % | $767,368 | $758,869 | $-8,499 | -1.10 % | $-50 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2004-04-12 | 2004-03-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 13,411 | Sold Some | -297 | -2.16 % | $789,237 | $754,369 | $-34,869 | -4.41 % | $772 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2004-03-17 | 2003-12-31 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 13,708 | Sold Some | -900 | -6.16 % | $840,300 | $771,075 | $-69,225 | -8.23 % | $4,545 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2004-03-17 | 2003-09-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 14,608 | Sold Some | -309 | -2.07 % | $895,470 | $821,700 | $-73,770 | -8.23 % | $1,560 | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
| 2004-03-17 | 2003-06-30 | 13F-HR | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 14,917 | No Compare | - | - % | $914,412 | $839,081 | $-75,331 | -8.23 % | | | | | | | History of Bryn Mawr Trust Co Ownership Of Amgen Inc |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |